Elucidata Expands Leadership Team with AI and Biotech Experts
-57aa4477-192a-4bd0-98b2-8ad2d2b67627.png&w=96&q=75){kind=small}
Slice of Technology Team
03/03/2025
Key Highlights:
- Elucidata appoints Dr. Werner Lanthaler as Independent Board Member and Dr. Navjot Singh as Advisor.
- Recognized as Fast Company’s Most Innovative Biotech Company and winner of National Cancer Institute's AI-Readiness Challenge.
- Dr. Lanthaler brings biotech leadership and innovation expertise from Evotec SE and Wlanholding.
- Dr. Singh, a Senior Partner Emeritus at McKinsey & Co., specializes in AI, healthcare, and digital transformation.
- Elucidata advances AI-ready data solutions, ensuring data quality as a service for biopharma R&D.
Source: Business Wire
Quotes
“ “Elucidata is on a strong growth trajectory, enabling biopharma R&D organizations to fully realize the potential of AI.” ”
Dr. Werner Lanthaler, Independent Board Member at Elucidata
Why This Matters:
As AI reshapes life sciences, healthcare, and diagnostics, data quality remains a critical challenge. Elucidata’s human-in-the-loop approach and cutting-edge AI solutions ensure that organizations can accelerate innovation with reliable, AI-ready data. The addition of Dr. Lanthaler and Dr. Singh strengthens Elucidata’s leadership, positioning it to drive breakthroughs in precision medicine and biopharma R&D.
-57aa4477-192a-4bd0-98b2-8ad2d2b67627.png&w=48&q=75){kind=small}
